In particular, patients with combined HCC-ICC having co-overexpression of DDR1 and PROM1 had the worst survival, suggesting the contribution of PROM1+ TICs to this clinical phenotype. The gene discussed is PROM1; the disease is intrahepatic cholangiocarcinoma.